Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

BACKGROUND: Carbapenems are recommended treatment for serious infections caused by AmpC-producing gram-negative bacteria but can select for carbapenem resistance. Piperacillin-tazobactam may be a suitable alternative. METHODS: We enrolled adult patients with bloodstream infection due to chromosomal...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Adam G, Paterson, David L, Young, Barnaby, Lye, David C, Davis, Joshua S, Schneider, Kellie, Yilmaz, Mesut, Dinleyici, Rumeysa, Runnegar, Naomi, Henderson, Andrew, Archuleta, Sophia, Kalimuddin, Shirin, Forde, Brian M, Chatfield, Mark D, Bauer, Michelle J, Lipman, Jeffrey, Harris-Brown, Tiffany, Harris, Patrick N A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361238/
https://www.ncbi.nlm.nih.gov/pubmed/34395716
http://dx.doi.org/10.1093/ofid/ofab387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361238/
https://www.ncbi.nlm.nih.gov/pubmed/34395716
http://dx.doi.org/10.1093/ofid/ofab387

Ejemplares similares